Feasibility assessment of in vitro chemoresponse assay on stereotactic biopsies of glioblastoma multiforms: a step towards personalized medicine

OBJECTIVE(S): P In vitro chemosensitivity and resistance assays (CSRAs) are a promising tool for personalized treatment of glioblastoma multiform (GBM). These assays require a minimum of 1 to 2 g of tumor specimen for testing, but this amount is not always accessible. We aimed to assess the feasibil...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeghi Fazel, Fariba, Haddadi, Mahnaz, Khoshnevisan, Alireza, Muhammadnejad, Samad, Muhammadnejad, Ahad, Mazaheri, Zohreh, Arjomandnejad, Motahareh, Shirkoohi, Reza, Oghabian, Mohammad-Ali, Sherkat-Khameneh, Narjes, Amanpour, Saeid, Kazemimanesh, Monireh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328103/
https://www.ncbi.nlm.nih.gov/pubmed/25691936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328103/
https://www.ncbi.nlm.nih.gov/pubmed/25691936

Ejemplares similares